Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

<< Previous
Bullboard Posts
Next >>
Post by prophetoffactzon Apr 16, 2023 1:57pm
123 Views
Post# 35397439

Interesting: Avenanthramide Obesity:

Interesting: Avenanthramide Obesity:
"reduced body weight gain by 9.6% and 14.8%"

"In conclusion, we studied the three main AVA extracts from oats and showed that consumption of AVA at 100 or 300 mg/kg per day reduced body weight gain by 9.6% and 14.8%, respectively, in C57BL/6 mice fed a high-fat diet. We discussed the primary mechanisms for this protective effect of AVA on obesity. AVA may alter body weight by alleviating oxidative stress and inflammation in diet-induced obesity. However, the specific AVA metabolic pathways affecting obesity are still unclear. Therefore, further clinical studies are needed."
Consumption of avenanthramides extracted from oats reduces weight gain, oxidative stress, inflammation and regulates intestinal microflora in high fat diet-induced mice - ScienceDirect
<< Previous
Bullboard Posts
Next >>